BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11487383)

  • 1. A case of leucodepletion failure in Cobe spectra plateletpheresis: further studies on the identification of the potential cause.
    Seghatchian J; Beard MJ; Krailadsiri P
    Platelets; 2001 Aug; 12(5):302-8. PubMed ID: 11487383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the improvement of leucodepletion performance of the Haemonetics MCS+ for production of leucodepleted platelet concentrate.
    Seghatchian J; Beard MJ; Krailadsiri P
    Platelets; 2001 Aug; 12(5):298-301. PubMed ID: 11487382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The content of the LRS chamber provides a new quality tool for the characterization of the donor platelet profile.
    Vasconcelos E; Sousa AP; Seghatchian J; Maurício R; Figueiredo AC; Leitão C; Sousa G
    Transfus Apher Sci; 2005 Apr; 32(2):221-5. PubMed ID: 15784457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal leucodepletion: an overview of some unresolved issues and the highlights of lessons learned.
    Seghatchian J
    Transfus Apher Sci; 2003 Oct; 29(2):105-17. PubMed ID: 12941346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quality of MCS+ version C2 double dose platelet concentrate with leucodepletion through a continuous filtration process.
    Seghatchian J; Krailadsiri P
    Transfus Apher Sci; 2002 Feb; 26(1):37-41. PubMed ID: 11931376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparison of plateletpheresis with the same donors using four blood separators at a single blood center.
    Tenorio GC; Strauss RG; Wieland MJ; Behlke TA; Ludwig GA
    J Clin Apher; 2002; 17(4):170-6. PubMed ID: 12494409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of in process qualification in quality improvement of the haemonetics MCS plus leucodepleted platelet concentrate.
    Seghatchian J; Beard M; Krailadsiri P
    Transfus Sci; 2000 Jun; 22(3):165-9. PubMed ID: 10831919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plateletpheresis with the new COBE Spectra.
    Kretschmer V; Rossa W; Eisenhardt G
    Infusionstherapie; 1991 Jun; 18 Suppl 1():24-8. PubMed ID: 1917060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the characterisation of the cause of leucoreduction failures, with particular reference to extra gatal events.
    Seghatchian J; Krailadsiri P; Beard M; Bukasa A; Bashir S
    Transfus Apher Sci; 2002 Feb; 26(1):47-60. PubMed ID: 11931378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fuji surge technique and continuous in-line filtration to improve the quality of single donor platelet concentrates.
    Moog R
    J Clin Apher; 2002; 17(4):199-203. PubMed ID: 12494413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
    Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
    J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic, laboratory, and operational variables that influence short- and long-term plateletpheresis yields.
    Badami KG; Sesun M; Basu A; Absalom N
    J Clin Apher; 2012 Nov; 27(5):247-54. PubMed ID: 22730096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors.
    Zingsem J; Zimmermann R; Weisbach V; Glaser A; van Waeg G; Eckstein R
    Transfusion; 1997 Oct; 37(10):1045-9. PubMed ID: 9354823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
    Fontana S; Mordasini L; Keller P; Taleghani BM
    Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator.
    Chaudhary R; Das SS; Khetan D; Sinha P
    Transfus Apher Sci; 2006 Apr; 34(2):157-61. PubMed ID: 16510315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucodepletion and immune response mechanisms.
    Semple JW
    Vox Sang; 2004 Jul; 87 Suppl 2():136-8. PubMed ID: 15209898
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of plateletpheresis using Baxter CS 3000 plus and Haemonetics MCS 3P.
    Patel AP; Kaur A; Patel V; Patel N; Shah D; Kanvinde S; Prajapati S; Patel H; Rathod D; Adesara R; Rani S
    J Clin Apher; 2004; 19(3):137-41. PubMed ID: 15493051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.